Sutro Biopharma (STRO) — Capital Reinvestment Ratio
Sutro Biopharma (STRO) has a Capital Reinvestment Ratio of 0.08x as of June 2024, meaning it reinvests 0% of its operating cash flow ($9.46 Million) in capital expenditures ($756.00K). Check STRO tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Sutro Biopharma Capital Reinvestment Ratio (2018–2022)
This chart tracks Sutro Biopharma's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see Sutro Biopharma operating cash flow efficiency.
Annual Capital Reinvestment Ratio for Sutro Biopharma (2018–2022)
Year-by-year Capital Reinvestment Ratio for Sutro Biopharma from 2018 to 2022. See how much free cash does Sutro Biopharma generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 2.21x | $3.55 Million | $7.86 Million | ▲ +1703.6% |
| 2018 | 0.12x | $12.68 Million | $1.56 Million | — |